Angioedema Associated With Premixed Insulin in a T2DM Patient

T2DM in youth has widely expanded over the past 20 years with evidence that type 2 diabetes in youth differs from type 2 diabetes in adults, having a rapidly progressive decline in b-cell function and accelerated development of diabetes complications.Our case presented a 15-year-old diabetic adolescent with childhood syndromic obesity (most probably Alstrom syndrome) treated as a case of T1DM that burdened her with unnecessary multiple daily injections and financial costs that even failed to control her blood sugar. Conclusion:It is important to be aware of the expanding prevalence of T2DM among youth and adolescents stressing the need for early diagnosis and providing currently approved treatments which are Insulin, Metformin, SGLT2 or GLP1 with target A1C <7 %.